About Us   |   Contact Us   |  
Submission  

Neurobiology and Management of Attention-Deficit/Hyperactivity Disorder and Co-Occurring Major Depressive Disorder: Complications and Strategies

DOI : https://doi.org/10.36349/easjpp.2020.v02i06.005
PDF
HTML
XML

Abstract: Attention-deficit/hyperactivity disorder (ADHD) is a contentious diagnostic issue, which has been increasing in prevalence in recent years, and is often comorbid with major depressive disorder (MDD). The common features of ADHD and MDD are altered activation of brain regions involved in rewarding processing and monoamine signalling. ADHD responds well to a multimodal treatment that consists of pharmacological and psychosocial interventions. Its treatment responsiveness improves mood and well-being. There is persistent debate around the use of catecholaminergic agents such as psychostimulants both in ADHD and in the treatment of depression. This review will focus on the neurobiology of both psychopathologies and how they intertwine, and consider the potential benefits and adverse effects of catecholaminergic agents in the treatment of ADHD and co-occurring MDD.

TOP EDITORS

OPEN ACCESS JOURNALS

Dr. Afroza Begum

Lecturer, Dept. of Pharmacology and Therapeutics, Shaheed Monsur Ali Medical College & Hospital, Uttara, Dhaka-1230, Bangladesh

BEST AUTHOR

Of The Month

TRACK YOUR ARTICLE

Enter the Manuscript Reference Number (MRN)
Get Details

Contact us


EAS Publisher (East African Scholars Publisher)
Nairobi, Kenya


Phone : +91-9365665504
Whatsapp : +91-8724002629
Email : easpublisher@gmail.com

About Us


EAS Publisher (East African Scholars Publisher) is an international scholar’s publisher for open access scientific journals in both print and online publishing from Kenya. Its aim is to provide scholars ... Read More Here

*This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.

© 2020, All Rights Reserved | SASPR Edu International Pvt. Ltd.

Developed by JM